National Action Plan on Antimicrobial Resistance 2017 – 2022.

The plan is coherent to the WHO Global Action Plan on antimicrobial resistance (AMR) with the following strategic objectives: improve awareness and understanding of antimicrobial resistance through effective communication, education and training; strengthen the knowledge and evidence base through surveillance and research; reduce the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimize the use of antimicrobial medicines in human and animal health; and develop the economic case for sustainable investment that takes account of the needs of all countries and to increase investment in new medicines, diagnostic tools, vaccines and other interventions. The situational analysis outlines the current AMR position in the country. The document summarizes the structure for the development and implementation of the National Action Plan. It specifies the establishment of the National AMR Coordinating Committee, the Technical Working Groups, the Secretariat and the AMR Focal Point. It further describes the implementation structure at different levels.
The Strategic Plan provides details of the priority actions, specific objectives, interventions and key activities to be performed for each strategic objective. Ten priority actions have been identified with several interventions. The deliberated initiatives includes the establishment of an evidence-based public communication Health Programme that targets human and animal health and the environment, including consideration of the food chain; advocacy campaign for AMR; establishment of knowledge management and sharing mechanisms at all levels; inclusion of AMR as a core component of professional education, training, certification and development. A National Multi-Sectoral Coordinating Committee on AMR is the central National steering body and shall oversee and coordinate all AMR related activities in all sectors. The AMR Action plan operations shall be managed and implemented through the MCC under the chairmanship of the Chief Medical Officer and co-chaired by the WHO Representative to Tanzania.
The five strategic objectives are to be operationalized in order to achieve the desired results of this plan. In each strategic objective, the priority actions, specific objectives, interventions and key activities have been identified. Strategic Objectives: 1. Create Awareness and Understanding of Antimicrobial Resistance through Effective Information, Education and Communication; 2. Strengthen the Knowledge and Evidence Based through Surveillance and Research; 3. Reduce the Incidence of Infection through Effective Sanitation, Hygiene and Infection Prevention Measures; 4. Optimize the Use of Antimicrobial Agents in Human and Animal Health; 5. Develop the Economic Case for Sustainable Investment that Takes Account of the Needs of all Countries and to Increase Investment in New Medicines, Diagnostic Tools, Vaccines and other Interventions. Priority Actions are: 1. Awareness-Raising and Risk Communication; 2. Education; 3. Surveillance System; 4. Laboratory Capacity; 5. Research and Development; 6. Infection Prevention and Control in Health Care; 7. Health Waste Management System; 8. Regulatory Framework for Preservation of Antimicrobial Agents; 9. Antimicrobial Stewardship Programmes; 10. Sustainability of Antimicrobial Resistance Interventions.